NephroGenex's Asset Sale

NephroGenex raised a round of funding on May 16, 2017. Investors include Medpace.

NephroGenex is a pharmaceutical company focused on the development of therapeutics to treat kidney disease, an area of significant unmet medical need. Since inception, the company has collaborated wit…

Articles about NephroGenex's Asset Sale: